Happy pets. Happy vets. CYTOPOINT increases client visits and interactions
CYTOPOINT led to 39% more practice visits compared with other atopic dermatitis therapies2*
10 visits per year versus 7 visits per year before using CYTOPOINT2
What could you do if you saw your patients more often?
Identify and intervene early if flares occur2
Educate owners on the benefits of other services and provide overall wellness care (eg, dental work and year-round parasite prevention)2
Improve patient health and strengthen client loyalty and trust2
In a retrospective study, the medical records of 174 dogs with atopic dermatitis and treated by dermatologists were assessed for 12 months before and 12 months after starting CYTOPOINT treatment. Therapy during both periods was unrestricted and could include (but was not limited to) corticosteroids, antibiotics, allergen-specific immunotherapy, medicated shampoos, prescription diets and topical therapy. Data gathered from the medical records included number of clinic visits and cost of professional fees, services and products dispensed for the management of atopic dermatitis during both time periods.
Dermatologists offer the gold standard in skin care, and are likely to offer pet owners the full extent of available treatment options.
†Repeat administration every 4 to 8 weeks as needed in individual patients.
Indication: CYTOPOINT aids in the reduction of clinical signs associated with atopic dermatitis in dogs.
References: 1. Data on file, APOQUEL/CYTOPOINT Vet Tracker Wave 9, 2018, Zoetis Inc. 2. Data on file, Study No. 16SORDER0101, Zoetis Inc. 3. Data on file, APOQUEL/CYTOPOINT Pet Tracker Wave 5, 2017, Zoetis Inc. 4. Data on file, Study Report No. C863R-US-12-018, Zoetis Inc. 5. Data on file, IL-31 Pricing Report, February 2015, Zoetis Inc.
This site is intended for U.S. Animal Healthcare Professionals. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.